Monocarboxylate transporter 2 regulates maintenance of myelin and axonal integrity by oligodendrocytes
Myelin alterations, tightly linked to axonal degeneration, are common in neurodegenerative diseases, including multiple sclerosis (MS). However, the metabolic mechanisms that sustain white matter integrity remain elusive. Monocarboxylates are important energy fuels, but their role in myelinating oligodendrocyte function remains unclear. Here, we show that myelinating oligodendrocytes express high affinity monocarboxylate transporter 2 (MCT2), which is downregulated in progressive MS. While deletion of MCT2 in the mouse spinal white matter using oligodendrotropic AAV injection does not affect oligodendrocyte survival, it downregulates lipid synthesis-associated enzymes and increases inflammation, leading to a failure of myelin maintenance. These changes, not evidenced in AAV-control mice that only show mild inflammation, are accompanied by axonal upregulation of lactate dehydrogenase A and injury, effects alleviated by ketogenic diet. Therefore, our findings show that oligodendroglial MCT2 regulates myelin maintenance and axonal support under mild inflammation. This appears disrupted in progressive MS but might be compensated for by specific metabolic therapies to preserve white matter integrity. Metabolic determinants of white matter integrity remain elusive. Here, the authors show downregulation of MCT2 in oligodendrocytes in progressive MS, and then demonstrate its role in myelin maintenance in mice, where the effects of MCT2 loss can be alleviated by a ketogenic diet.
Authors
- Carlos Matute (ORCID: https://orcid.org/0000-0001-8672-711X)
- Cyrille Deboux
- Vanja Tepavčević (ORCID: https://orcid.org/0000-0003-3230-4888)
- José Manuel García‐Verdugo (ORCID: https://orcid.org/0000-0001-9872-6499)
- Alejandro Carretero‐Guillén (ORCID: https://orcid.org/0000-0003-2370-2534)
- Marı́a Domercq (ORCID: https://orcid.org/0000-0002-4918-9276)
- Raquel Morales‐Gallel (ORCID: https://orcid.org/0009-0006-1593-4334)
- Laura Merino‐Cacho (ORCID: https://orcid.org/0000-0003-1551-4074)
- Luc Pellerin (ORCID: https://orcid.org/0000-0002-1016-1970)
- Brahim Nait‐Oumesmar (ORCID: https://orcid.org/0000-0002-1646-6281)
- Francisco García‐García (ORCID: https://orcid.org/0000-0001-8354-5636)
- Irene Soler-Sáez (ORCID: https://orcid.org/0000-0002-5210-7470)
- Mauricio Lopez Portillo Masson (ORCID: https://orcid.org/0000-0002-8555-3215)
- Leire Izagirre‐Urizar (ORCID: https://orcid.org/0000-0003-3352-8373)
- Citlalli Netzahualcoyotzi (ORCID: https://orcid.org/0000-0002-7870-1689)
- Stefano Calovi (ORCID: https://orcid.org/0000-0003-4979-8079)
- María Andrés-Bilbao
- José L. Zugaza
- Luna Mora-Huerta
- Juan-Carlos Chara
- Maria-Jose Ulloa-Navas
Institutions
- Ikerbasque (ES)
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Universitat de València (ES)
- University of the Basque Country (ES)
- Parc Científic de la Universitat de València (ES)
- Instituto de Salud Carlos III (ES)
- WinnMed (US)
- Université de Poitiers (FR)
- Sorbonne Université (FR)
- BioCruces Health research Institute (ES)
- Achucarro Basque Center for Neuroscience (ES)
- Institut de Myologie (FR)
- Mayo Clinic in Florida (US)
- Institut du Cerveau (FR)
- Centro de Investigacion Principe Felipe (ES)
- Instituto Politécnico Nacional (MX)
Publication Details
- Journal
- Nature Communications
- Published
- 2026-06-18
- DOI
- https://doi.org/10.1038/s41467-026-74488-w
- Primary Topic
- Neurogenesis and neuroplasticity mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00